Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.

[1]  Aad van der Lugt,et al.  Prevalence and Risk Factors of Cerebral Microbleeds: An Update of the Rotterdam Scan Study , 2010, Stroke.

[2]  R. Righart,et al.  Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts , 2015, Neurology.

[3]  K. D. de Laat,et al.  Cerebral White Matter Lesions and Lacunar Infarcts Contribute to the Presence of Mild Parkinsonian Signs , 2012, Stroke.

[4]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[5]  Gert Jan Lammers,et al.  Assessment of sleep and sleepiness in Parkinson disease. , 2003, Sleep.

[6]  R. Barker,et al.  Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? , 2016, Movement disorders : official journal of the Movement Disorder Society.

[7]  K. Jellinger.  Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study , 2003, Acta Neuropathologica.

[8]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[9]  D. Norris,et al.  Cerebral small vessel disease and incident parkinsonism , 2015, Neurology.

[10]  N. Xiong,et al.  Immune Reconstitution Inflammatory Syndrome Secondary to Autoimmune Hemolytic Anemia and Cryptococcal Meningitis , 2019, Front. Neurol..

[11]  I. McKeith,et al.  SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders , 2003, Movement disorders : official journal of the Movement Disorder Society.

[12]  Y. Sohn,et al.  Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease. , 2015, Parkinsonism & related disorders.

[13]  Charles DeCarli,et al.  White matter hyperintensities and cognition: Testing the reserve hypothesis , 2011, Neurobiology of Aging.

[14]  J. Kaye,et al.  Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline , 2008, Neurology.

[15]  Ivan Rektor,et al.  An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group. , 2017, Parkinsonism & related disorders.

[16]  K. Kitagawa,et al.  Association between cerebral small vessel diseases and mild parkinsonian signs in the elderly with vascular risk factors. , 2016, Parkinsonism & related disorders.

[17]  L. Radloff.  The CES-D Scale , 1977 .

[18]  H. Markus,et al.  Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease , 2016, Brain : a journal of neurology.

[19]  D. Norris,et al.  Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol , 2011, BMC neurology.

[20]  Yung-Yee Chang,et al.  The relationship of leukoaraiosis and the clinical severity of vascular Parkinsonism , 2014, Journal of the Neurological Sciences.

[21]  A. Hofman,et al.  Incidental findings on brain MRI in the general population. , 2007, The New England journal of medicine.

[22]  Amos D. Korczyn,et al.  Vascular parkinsonism—characteristics, pathogenesis and treatment , 2015, Nature Reviews Neurology.

[23]  P. Satz.  Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. , 1993 .

[24]  Andrew J Lees,et al.  Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis , 2004, Movement disorders : official journal of the Movement Disorder Society.

[25]  Nicolaas I. Bohnen,et al.  White matter lesions in Parkinson disease , 2011, Nature Reviews Neurology.

[26]  F. Aversa,et al.  Competing risk analysis using R: an easy guide for clinicians , 2007, Bone Marrow Transplantation.

[27]  Nico Karssemeijer,et al.  Automated detection of white matter hyperintensities of all sizes in cerebral small vessel disease. , 2016, Medical physics.

[28]  A. Stefani,et al.  The relationship between cerebral vascular disease and parkinsonism: The VADO study. , 2012, Parkinsonism & related disorders.

[29]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[30]  R. Albin,et al.  Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. , 2011, Brain : a journal of neurology.

[31]  Y. Stern.  What is cognitive reserve? Theory and research application of the reserve concept , 2002, Journal of the International Neuropsychological Society.